The use of bemiparin in obstetric antiphospholipid syndrome
- Authors: Tetruashvili NK1, Ionanidze TB1, Agadzhanova AA1, Menzhinskaya IV1
-
Affiliations:
- V.I.Kulakov Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation
- Issue: Vol 17, No 3 (2015)
- Pages: 49-51
- Section: Articles
- URL: https://ogarev-online.ru/2079-5831/article/view/28454
- ID: 28454
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
N K Tetruashvili
V.I.Kulakov Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation
Email: insufficiencytetrauly@mail.ru
д-р мед. наук, рук. 2-го акушерского отд-ния патологии беременности ФГБУ НЦАГиП им. акад. В.И.Кулакова 1179974, Russian Federation, Moscow, ul. Akademika Oparina, d. 4
T B Ionanidze
V.I.Kulakov Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation
Email: teona_21@rambler.ru
науч. сотр. 2-го акушерского отд-ния патологии беременности ФГБУ НЦАГиП им. акад. В.И.Кулакова 1179974, Russian Federation, Moscow, ul. Akademika Oparina, d. 4
A A Agadzhanova
V.I.Kulakov Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation
Email: aagadjanova@mail.ru
д-р мед. наук, вед. науч. сотр. 2-го акушерского отд-ния патологии беременности ФГБУ НЦАГиП им. акад. В.И.Кулакова 1179974, Russian Federation, Moscow, ul. Akademika Oparina, d. 4
I V Menzhinskaya
V.I.Kulakov Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation
Email: menirvl@gmail.com
канд. мед. наук, ст. науч. сотр. лаб. клинической иммунологии ФГБУ НЦАГиП им. акад. В.И.Кулакова 1179974, Russian Federation, Moscow, ul. Akademika Oparina, d. 4
References
- Abbasi N, Balayla J, Laporta D.P et al. Trends, risk factors and mortality among women with venous thromboembolism during labour and delivery: a population - based study of 8 million births. Arch Gynecol Obstet.
- Palareti G. Pregnancy and venous thrombosis [haematologica reports] 2005; 1 (10): 13-7.
- Stein P.D, Hull R.D, Kayali F et al. Venous thromboembolism in pregnancy: 21-year trends. Am J Med 2004; 117: 121-5.
- Тетруашвили Н.К. Клинико - анамнестический анализ и структура причин привычных ранних потерь беременности. Врач. 2008; 7.
- Cervera R, Font J, Gomez Puerta J.A et al. Catastrophic Antiphospholipid Syndrome Registry Project Group. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis 2005; 64: 1205-9.
- Серов В.Н., Сидельникова В.М., Агаджанова А.А., Тетруашвили Н.К. Плацентарная недостаточность в клинике невынашивания беременности. Рус. мед. журн. 2003; 11 (16): 938-40.
- Антифосфолипидный синдром в акушерской практике. Под ред. А.Д.Макацария. М.: Руссо, 2000.
- Макацария А.Д., Бицадзе В.О. Тромбофилии и противотромботическая терапия в акушерской практике. М.: Триада-Х, 2003.
- Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений. Флебология. 2010; 4 (1): 42.
- Bick R.L, Frenkel E.P, Backer W.F, Sarode R. Hematological complications in obstetrics, pregnancy, and gynecology. UK, Cambridge University press, 2006; p. 604.
- Lumpkin M.M. FDA public health advisory. Anesthesiology 1998; 88: 27A-28A.
- Navarro-Quilis A et al. Efficacy and safety of bemiparin compared with enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: a randomized, double - blind clinical trial; J Thromb Haemost 2003; 1 (3): 425-32.
- Pettker C, Lockwood C. Pregnancy and venous thrombosis. The Global Library of Women’s Medicine.
- Brenner B. Haemostatic changes in pregnancy. Thromb Res 2004; 114 (5-6): 409-14.
- Brill-Edwards P, Ginsberg J.S, Gent M et al. Recurrence of Clot in This Pregnancy Study Group Safety of withholding heparin in pregnant women with a history of venous thromboembolism. N Engl J Med 2000; 343 (20): 1439-44.
- Шулутко Е.М. Бемипарин - низкомолекулярный гепарин второго поколения в лечении и профилактике венозных тромбоэмболий. Трудный пациент. 2007; 15-16: 5-10.
- Gómez-Outes A, Rocha E, Martínez-González J, Kakkar V.V. Cost effectiveness of bemiparin sodium versus unfractionated heparin and oral anticoagulants in the acute and long - term treatment of deep vein thrombosis. Pharmacoeconomics 2006; 24: 81-92.
Supplementary files
